Charles Schwab Investment Management »

Protagonist Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 455k 22.93
2023-09-30 $7.3M 439k 16.68
2023-06-30 $12M 420k 27.62
2023-03-31 $8.3M 361k 23.00
2022-12-31 $3.7M 340k 10.91
2022-09-30 $2.8M 334k 8.43
2022-06-30 $2.6M 325k 7.91
2022-03-31 $7.7M 325k 23.68
2021-12-31 $11M 317k 34.20
2021-09-30 $5.5M 310k 17.72
2021-06-30 $13M 281k 44.88
2021-03-31 $6.8M 262k 25.90
2020-12-31 $4.5M 225k 20.16
2020-09-30 $4.2M 217k 19.55
2020-06-30 $1.0M 57k 17.66
2020-03-31 $310k 44k 7.06
2019-12-31 $309k 44k 7.06
2019-09-30 $488k 41k 12.02
2019-06-30 $442k 37k 12.12
2018-03-31 $278k 32k 8.60
2017-12-31 $402k 19k 20.83
2017-09-30 $234k 13k 17.73
2017-06-30 $150k 13k 11.36
2017-03-31 $170k 13k 12.88
2016-12-31 $291k 13k 22.05